clinical trial · NCT04437199
Tricaprilin Phase 2 Pilot Study in Migraine
Cerecin·phase2·completed·n = 83
MigraineTricaprilinPlacebo
brief summary
This is a randomised, double-blind, placebo-controlled, parallel-group, multi-centre study of tricaprilin as AC-SD-03 compared with placebo for the reduction of migraine in participants with frequent migraine.
started
Dec 17, 2020
primary completion
Feb 7, 2022
completion
Feb 7, 2022
last updated
Feb 8, 2024
official title
A 12-Week, Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Investigate the Efficacy and Safety of Daily Administration of Tricaprilin as AC-SD-03 in Participants With Migraine
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol